Telehealth

Advocates warn that systemic delays under Jordan's Principle are denying First Nations and Inuit children the essential healthcare they are legally owed.

Midwest retailer Meijer partners with WellSync to offer $29.99 virtual care visits with no insurance, challenging competitors like CVS and Walmart.

The Canadian fertility network appoints former CFO Heather Stark as its first female CEO, signaling a strategic shift toward operational excellence and growth.

A novel cell therapy for Parkinson's earns a key FDA designation, signaling a potential paradigm shift from managing symptoms to reversing the disease.

Carrying the Alzheimer's gene, a longevity expert has turned himself into a public experiment, documenting his radical protocol to prevent the disease.

Equinox's new EQX ARC program partners with Oura and Function to offer hyper-personalized, data-driven training for women across all life stages.

Kaiser Permanente hires veteran strategist Beth Leonard for a new C-suite role, signaling a major push to influence policy and export its care model.

A new report warns a patchwork of state AI laws is stifling innovation and calls for a unified national framework to ensure safe, equitable patient care.

New England Donor Services celebrates a record year with innovative tech, but looming federal policy changes threaten the entire organ donation system.

With 15,000 patients served and a 75% in-person preference, SOL Mental Health's 2025 growth shows a powerful demand for local, data-driven care.

From developing neonatal ventilators to pivotal COVID vaccine research, a San Antonio institute marks 85 years on the front lines of global health.

Meet the silent heroes and advanced technologies giving America's veterans a new lease on life, thanks to the targeted efforts of nonprofit SoldierStrong.

Adial Pharmaceuticals files a key patent to protect its personalized Alcohol Use Disorder drug, AD04, until 2045, signaling a new era for addiction medicine.

The deal merges Firstsource's AI prowess with TeleMedik's operational footprint, aiming to cut costs for health plans and expand care to new communities.

A coalition of top GOP senators and state attorneys general is urging the FDA to pull mifepristone, escalating the fight over abortion to the federal level.

With a fresh $33M investment, HPS/PayMedix is expanding its interest-free financing platform nationwide to tackle soaring patient medical bills.

The first-ever Wegovy pill is now available via telehealth platform Ro, offering a cash-pay option that could revolutionize access to weight loss drugs.

Following a $25M fundraise, former WA Health Secretary Dr. Shah joins Jaan Health, signaling a new era for AI-driven chronic disease management.

MediKarma is licensing autonomous AI agents to manage disease and data, aiming to become the core processor for the entire healthcare industry.

After a strategic pivot reverses a year of decline, Allurion's preliminary results show new growth. All eyes are now on the FDA for its 'procedureless' gastric balloon.